Black Rock Inc. Immunity Bio, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 11,423,089 shares of IBRX stock, worth $51.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,423,089

Previous 10,375,311 10.1%

Holding current value

$51.3 Million

Previous $55.7 Million 29.58%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.82 - $9.15 $5.05 Million - $9.59 Million	1,047,778 Added 10.1%	11,423,089 $72.2 Million
Q1 2024 May 10, 2024	SELL	$3.23 - $6.17 $1.08 Million - $2.07 Million	-334,868 Reduced 3.13%	10,375,311 $55.7 Million
Q4 2023 Feb 13, 2024	SELL	$1.25 - $5.21 $126,065 - $525,438	-100,852 Reduced 0.93%	10,710,179 $53.8 Million
Q3 2023 Nov 13, 2023	BUY	$1.29 - $3.1 $1.69 Million - $4.07 Million	1,312,365 Added 13.82%	10,811,031 $18.3 Million
Q2 2023 Aug 11, 2023	BUY	$1.53 - $6.41 $3.88 Million - $16.2 Million	2,533,147 Added 36.37%	9,498,666 $26.4 Million
Q1 2023 May 12, 2023	SELL	$1.35 - $4.78 $73,730 - $261,059	-54,615 Reduced 0.78%	6,965,519 $12.7 Million
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $3.49 Million - $5.44 Million	802,935 Added 12.91%	7,020,134 $35.6 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $1.13 Million - $1.99 Million	309,550 Added 5.24%	6,217,199 $30.9 Million
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $2.13 Million - $4.88 Million	794,776 Added 15.54%	5,907,649 $22 Million
Q1 2022 May 12, 2022	SELL	$5.05 - $7.53 $1.16 Million - $1.72 Million	-228,945 Reduced 4.29%	5,112,873 $28.7 Million
Q4 2021 Feb 10, 2022	SELL	$5.67 - $10.18 $1.19 Million - $2.14 Million	-209,750 Reduced 3.78%	5,341,818 $32.5 Million
Q3 2021 Nov 09, 2021	BUY	$9.17 - $14.24 $2.55 Million - $3.96 Million	278,411 Added 5.28%	5,551,568 $54.1 Million
Q2 2021 Aug 11, 2021	BUY	$13.41 - $22.4 $70.7 Million - $118 Million	5,273,157 New	5,273,157 $75.3 Million

Others Institutions Holding IBRX

# of Institutions

202

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account